Blackstone’s RVL Pharmaceuticals RVLP Stock Holding History
Bought
Maintained
Sold
Other funds holding RVLP
Blackstone's RVLP Position: Q4 2023 in Review
Blackstone sold out of RVL Pharmaceuticals (RVLP) in Q4 2023, closing a stake of 632,264 shares — an estimated $56.9K sold.
Blackstone first reported a position in RVLP in Q3 2023 and held it in 1 quarter. The position peaked at $56.9K in Q3 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.
- Blackstone reported no remaining RVL Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
- Blackstone sold 632,264 RVL Pharmaceuticals shares in Q4 2023, an estimated $56.9K.
- Blackstone first reported a position in RVL Pharmaceuticals in Q3 2023 and held it in 1 quarter.
- Blackstone's RVL Pharmaceuticals position peaked at $56.9K in Q3 2023.
- 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals as of Q4 2023.
Based on Blackstone's 13F filing for Q4 2023, filed 14 Feb 2024.